Effect of massive cerebellar infarction on the outcomes of patients with acute basilar artery occlusion during hospitalization after endovascular treatment: A retrospective study.

Acute basilar artery occlusion (ABAO) after endovascular treatment (EVT) is often associated with a poor prognosis, particularly in patients with cerebellar infarction who may develop malignant cerebellar edema. The present study aimed to investigate how massive cerebellar infarction (MCI) affects hospitalization outcomes in ABVO patients who undergo EVT. We conducted a retrospective study of ABVO patients who underwent EVT at our hospital between September 2017 and September 2022. MCI was diagnosed using imaging techniques, and various prognostic scores were assessed during hospitalization to examine the relationship between MCI and these outcomes. We identified 42 ABAO patients, of whom 22 (52.4%) had MCI. Patients with MCI had a higher modified Rankin Scale (mRS) score at discharge compared to those without MCI (4.36 ± 1.14 vs 3.05 ± 1.85, P = .042, odds ratio [OR] (95% confidence interval [CI]) = 1.093 (0.083, 2.103)), and a lower Glasgow Coma Scale score (6.59 ± 4.0 vs 10.10 ± 5.07, P = .036, OR (95% CI) = -3.444 (-6.518, -0.369)). MCI was identified as an independent risk factor for an extremely poor prognosis (mRS ≥ 5) at discharge (P = .036, OR (95% CI) = 15.531 (1.603, 313.026)) and for no improvement in mRS score compared to onset (P = .013, OR (95% CI) = 0.025 (0.001, 0.274)). Additionally, an extremely poor prognosis was independently associated with stent implantation, EVT duration, and body mass index, while mRS score improvement was correlated with EVT duration and pulmonary infection. MCI in ABAO patients is a significant independent risk factor for a poor prognosis at discharge and no improvement in function score compared to onset. Early diagnosis and intervention are necessary to improve outcomes, particularly in high-risk populations.

[1]  Qingwu Yang,et al.  Neutrophil Count Predicts Malignant Cerebellar Edema and Poor Outcome in Acute Basilar Artery Occlusion Receiving Endovascular Treatment: A Nationwide Registry-Based Study , 2022, Frontiers in Immunology.

[2]  K. Toyoda,et al.  Endovascular Therapy for Acute Stroke with a Large Ischemic Region. , 2022, The New England journal of medicine.

[3]  Jinggang Xuan,et al.  Predictors of Functional Outcome and Mortality in Endovascular Treatment for Acute Basilar Artery Occlusion: A Single-Centre Experience , 2021, Frontiers in Neurology.

[4]  F. Gao,et al.  Novel Diffusion-Weighted Imaging Score Showed Good Prognostic Value for Acute Basilar Artery Occlusion Following Endovascular Treatment , 2021, Stroke.

[5]  C. Majoie,et al.  From Three-Months to Five-Years: Sustaining Long-Term Benefits of Endovascular Therapy for Ischemic Stroke , 2021, Frontiers in Neurology.

[6]  C. Roa-Mejía,et al.  Acute basilar artery occlusion (BAO): a pictorial review of multimodal imaging findings , 2021, Emergency Radiology.

[7]  K. Snyder,et al.  Comparison of effectiveness and outcomes among different thrombectomy techniques in acute basilar artery occlusion: a dual-center experience. , 2021, Neurosurgical Focus.

[8]  M. Mahmoudi,et al.  DWI cerebellar infarct volume as predictor of outcomes after endovascular treatment of acute basilar artery occlusion , 2020, Journal of NeuroInterventional Surgery.

[9]  Y. Lee,et al.  Association of pretreatment pontine infarction with extremely poor outcome after endovascular thrombectomy in acute basilar artery occlusion , 2020, Journal of NeuroInterventional Surgery.

[10]  K. Krakow,et al.  National Institutes of Health Stroke Scale (NIHSS) on admission predicts acute symptomatic seizure risk in ischemic stroke: a population-based study involving 135,117 cases , 2020, Scientific Reports.

[11]  R. Nogueira,et al.  Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry. , 2020, JAMA neurology.

[12]  F. Zhou,et al.  Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial , 2019, The Lancet Neurology.

[13]  X. Ji,et al.  Outcome of endovascular treatment for acute basilar artery occlusion in the modern era: a single institution experience , 2018, Neuroradiology.

[14]  M. Mazighi,et al.  Predictors for Mortality after Mechanical Thrombectomy of Acute Basilar Artery Occlusion , 2018, Cerebrovascular Diseases.

[15]  Thalia Shoshana Field,et al.  Suboccipital Decompressive Craniectomy for Cerebellar Infarction: A Systematic Review and Meta-Analysis. , 2017, World neurosurgery.

[16]  C. Caltagirone,et al.  The Basilar Artery on Computed Tomography Angiography Prognostic Score for Basilar Artery Occlusion , 2017, Stroke.

[17]  F. Gao,et al.  Endovascular Mechanical Thrombectomy with the Solitaire Device for the Treatment of Acute Basilar Artery Occlusion. , 2016, World neurosurgery.

[18]  A. Algra,et al.  Collateral flow predicts outcome after basilar artery occlusion: The posterior circulation collateral score , 2016, International journal of stroke : official journal of the International Stroke Society.

[19]  B. Baxter,et al.  Clinical and Procedural Predictors of Outcomes From the Endovascular Treatment of Posterior Circulation Strokes , 2016, Stroke.

[20]  P. Stanzione,et al.  Proposal for a Vascular Computed Tomography-Based Grading System in Posterior Circulation Stroke: A Single-Center Experience. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[21]  Y. Lee,et al.  Predictors of Good Outcome After Stent-Retriever Thrombectomy in Acute Basilar Artery Occlusion , 2015, Stroke.

[22]  F. Charvát,et al.  Endovascular treatment of acute basilar artery occlusion: time to treatment is crucial. , 2015, Clinical radiology.

[23]  T. Neumann-Haefelin,et al.  Mechanical recanalization in basilar artery occlusion: The ENDOSTROKE study , 2015, Annals of neurology.

[24]  M. Picot,et al.  Diffusion-Weighted Imaging Score of the Brain Stem: A Predictor of Outcome in Acute Basilar Artery Occlusion Treated with the Solitaire FR Device , 2014, American Journal of Neuroradiology.

[25]  G. Roglić,et al.  Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. , 2014, The lancet. Diabetes & endocrinology.

[26]  Max Wintermark,et al.  Recommendations for the Management of Cerebral and Cerebellar Infarction With Swelling: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2014, Stroke.

[27]  A. Algra,et al.  The Basilar Artery International Cooperation Study (BASICS): study protocol for a randomised controlled trial , 2013, Trials.

[28]  A. Algra,et al.  Time is Brain(stem) in Basilar Artery Occlusion , 2012, Stroke.

[29]  Gerhard Schroth,et al.  Basilar artery occlusion , 2011, The Lancet Neurology.

[30]  S. Uchiyama,et al.  Posterior circulation ASPECTS on diffusion-weighted MRI can be a powerful marker for predicting functional outcome , 2010, Journal of Neurology.

[31]  D. Tanné,et al.  Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study , 2009, The Lancet Neurology.

[32]  A. Jette,et al.  Uses of evidence in disability outcomes and effectiveness research. , 2002, The Milbank quarterly.

[33]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy , 2000, The Lancet.

[34]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[35]  W. Hacke,et al.  Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. , 1996, Stroke.

[36]  F. Laramée [Acute pulmonary infections]. , 1959, L'union medicale du Canada.

[37]  A. Qureshi,et al.  Current Endovascular Treatment of Acute Ischemic Stroke. , 2020, Missouri medicine.